Severe hepatic dysfunction (Child-Pugh C, score 10-15). Effectively contraindicates most...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-ORGAN-HEPATIC-CHILD-PUGH-C |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-27 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-AASLD-HCC-2023 SRC-NCCN-HCC-2025 |
Red Flag Origin
| Definition | Severe hepatic dysfunction (Child-Pugh C, score 10-15). Effectively contraindicates most cytotoxic and targeted systemic therapy. Best-supportive-care or strictly palliative regimens only; trial participation excluded. Liver transplant evaluation may take precedence over oncologic therapy in HCC. |
|---|---|
| Clinical direction | hold |
| Category | organ-dysfunction |
Trigger Logic
{
"all_of": [
{
"finding": "child_pugh_class",
"value": "C"
}
],
"type": "composite_score"
}
Notes
Child-Pugh C exclusion is near-universal across systemic-therapy trials. In HCC: only BSC or hospice referral typically; selected centers offer Y90 radioembolization in CP-C7-with-good-PS, but no systemic standard. In hematologic malignancies with secondary hepatic involvement (Hodgkin, DLBCL infiltrating liver), pre-phase prednisolone alone may improve LFTs sufficiently to allow attenuated R-CVP within 1-2 weeks — reassess after pre-phase. Direction `hold` rather than `de-escalate` because no evidence-supported attenuation guarantees safety here.
Used By
Algorithms
ALGO-HCC-SYSTEMIC-1L- ALGO-HCC-SYSTEMIC-1L